Association between GRM3 gene polymorphisms and response to treatment in Moroccan schizophrenic patients - 08/07/17
Résumé |
Objective |
The aim of this study is to evaluate the association between response to treatment in Moroccan schizophrenic patients and GRM3 gene polymorphisms.
Method |
We have genotyped three SNPs of GRM3 gene (rs1989796, rs1468412, rs1476455) in 33 Moroccan schizophrenic patients. We assessed the severity of symptoms using Positive and Negative Symptoms Scale (PANSS) and Brief Psychiatric Rating Scale (BPRS) during two months of antipsychotics treatment.
Results |
The result revealed a positive change in PANSS negative symptoms in patients with rs1468412SNP and a difference in allele frequency of rs1989796SNP between responders and nonresponders to treatment.
Conclusion |
Our data indicate that rs1468412 and rs1989796 GRM3 gene polymorphisms play a role in response to schizophrenia treatment.
Le texte complet de cet article est disponible en PDF.Plan
Vol 41 - N° S
P. S818 - avril 2017 Retour au numéro
Article précédent
- Comparison of cortisol levels in patients with schizophrenia and in healthy controls
- K.M. Wilczy?ski, D. Tobolska, M. Lorek, E. Mazgaj, A. Gawlik, K. Krysta
- Remission and recovery from first-episode psychosis in adults: A systematic review and meta-analysis of long-term outcome studies
- J. Lally, O. Ajnakina, B. Stubbs, M. Cullinane, K.C. Murphy, F. Gaughran, R.M. Murray
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?